REGISTRATION IS NOW OPEN!!!
Heart Attack and Stroke Prevention Conference on Nov 8-9, 2019 in Louisville, KY. Register Now!!! https://go.prevmedheartrisk.com/squee...
Join the PrevMed Community: https://mailchi.mp/1224fb9e00e7/prevm...
For information regarding our services or to become a patient visit: https://prevmedheartrisk.com/
ABOUT DR. BREWER
Dr. Brewer started as an Emergency Doctor. After seeing too many preventable heart attacks, he went to Johns Hopkins to learn Preventive Medicine. While there, he went on the run the post-graduate training program (residency) in Preventive Medicine. From there, he made a career of practicing and managing preventive medicine and primary care clinics. His later role in this area was Chief Medical Officer for Premise, which has close to 1,000 primary care/prevention clinics. He was also the Chief Medical Officer for MDLIVE, the second largest telemedicine company. More recently, he founded PrevMed, a heart attack, and stroke prevention clinic.
At PrevMed, we focus on heart attack, stroke, and cognitive decline. We serve patients who have already experienced an event as well as those who have not developed a diagnosis or event. Dr. Brewer provides services via telemedicine or in person if you're in the Lexington, KY area. We find a lot of undiagnosed Pre-Diabetes or Insulin Resistance. Treating unrecognized risk factors like Pre-Diabetes allows reduction of risk and prevention of disease.
If you are interested in becoming a patient, please visit our website: https://prevmedheartrisk.com/
ABOUT THIS VIDEO:
http://www.cardiobrief.org/2017/10/19...
http://imaging.onlinejacc.org/content...
In JACC, Oct 2017, (Jl of the American College of Cardiology), there was a beginning of a series on colchicine and heart attack/stroke prevention. This focus on cardiovascular inflammation (CV) inflammation was started again in June of 2017. It was tripped off by announcement of the CANTOS trial by Paul Ridker.
I review the cellular view of plaque inflammation. Then I talk about colchicine. Colchicine was first recorded as a treatment for arthritis, rheumatism, which is caused by similar inflammation of the joints. I review the Clinical Trials.gov site on the COLCOT study, an upcoming trial using colchicine.
Colchicine - An Old anti-inflammatory for CV inflammation - FORD BREWER MD MPH diseases caused by air pollution | |
| 117 Likes | 117 Dislikes |
| 3,803 views views | 52.2K followers |
| Science & Technology | Upload TimePublished on 29 May 2018 |
No comments:
Post a Comment